Over the past several decades, financing has emerged as a crucial element in the delivery of vaccines to US children. Until recently, an existing patchwork of financing from the public and private sectors has ensured that the vast majority of children have access to vaccines. However, recent stresses to this system have resulted in a growing crisis for both patients and providers. In this editorial, we trace the roots of this crisis, discuss its impact on patients and providers, and consider possible solutions to ensure that access to vaccines is preserved for all children.
Lee GM, Lieu TA. Vaccine Financing in the United States: An Emerging Crisis. Arch Pediatr Adolesc Med. 2009;163(5):485–487. doi:10.1001/archpediatrics.2009.70
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: